Lux Biosciences' Debt - IV Round

Lux Biosciences raised a round of funding on March 06, 2012.

Lux Biosciences is a clinical stage biotechnology company specializing in the development and commercialization of medications for serious ophthalmic diseases. With a product in NDA/MAA submission sta…

Articles about Lux Biosciences' Debt - IV Round: